Urethral Gonorrhea Test in Kathmandu NAAT on Urine or Swab — Site-Matched and Accurate

Overview

Urethral gonorrhea is infection of the urethra — the tube that carries urine and semen out of the body — caused by Neisseria gonorrhoeae. It is one of the most common bacterial STDs and the leading cause of urethritis in men. Infection typically produces burning urination, discharge and testicular discomfort, though many cases are mild or asymptomatic.

Diagnosis relies on nucleic acid amplification testing (NAAT) — the most sensitive method available. For urethral infection, NAAT can be performed on first-catch urine (the first part of the urine stream, which contains urethral cells and organisms) or on a swab of the urethral opening. Both methods are highly accurate and far superior to older microscopy or culture techniques.

Site-matched testing matters because gonorrhea can infect multiple sites simultaneously — the urethra, rectum and throat. A man who has receptive anal or oral sex may have rectal or pharyngeal infection without urethral symptoms. Testing only urine misses these extragenital infections, which is why the clinician asks about all sexual practices and samples each relevant site.

This page covers how urethral gonorrhea testing works, what symptoms to watch for, how results are interpreted, treatment options including ceftriaxone, partner management, and costs and confidentiality at Thamel Clinic in Kathmandu.

How Urethral Gonorrhea NAAT Works

Nucleic acid amplification testing detects the genetic material of Neisseria gonorrhoeae directly — far more sensitive and specific than older Gram stain or culture methods. For urethral infection, the preferred sample is first-catch urine: the patient voids the initial portion of the urine stream into a sterile container, which contains urethral cells and any organisms present.

Alternatively, a swab can be taken directly from the urethral opening — a brief, mildly uncomfortable procedure that collects cells from the infection site. Swab sampling is preferred when urine is not suitable or when extragenital sites need testing alongside.

The NAAT result is typically available within 24 to 48 hours. A positive result confirms gonorrhea; a negative result makes infection unlikely but does not absolutely exclude it if testing was done too early — the window period for NAAT is about 5 to 7 days post-exposure for most cases.

• NAAT detects Neisseria gonorrhoeae genetic material — most sensitive method
• First-catch urine: initial urine stream contains urethral cells and organisms
• Urethral swab: direct sampling from the urethral opening
• Results typically within 24 to 48 hours
• Window period: ~5–7 days post-exposure for reliable detection
• Site-matched: rectal and pharyngeal swabs added where indicated

Symptoms of Urethral Gonorrhea

The classic presentation is acute urethritis: burning or stinging on urination, a purulent yellow-green discharge from the penis, and sometimes blood in the urine or semen. Symptoms typically appear 2 to 7 days after exposure, though they can take up to two weeks.

Some men have milder symptoms — a slight discharge, mild burning or just an uncomfortable sensation — that are easily dismissed or self-treated. Others have no symptoms at all despite active infection, which is why testing after exposure matters even without symptoms.

Untreated urethral gonorrhea can spread upward to cause epididymitis — painful swelling of the testicle — or contribute to infertility. In rare cases it can disseminate to cause joint pain, rash or systemic infection (disseminated gonococcal infection), which is a medical emergency.

• Burning or stinging on urination — the most common symptom
• Purulent yellow-green urethral discharge
• Blood in urine or semen
• Testicular pain or swelling (epididymitis)
• Symptoms appear 2–7 days post-exposure typically
• Asymptomatic infection is common — testing still needed

Multi-Site Testing for Complete Coverage

Gonorrhea does not stay in one place. Men who have receptive anal sex can have rectal gonorrhea; those who perform oral sex on partners can have pharyngeal (throat) gonorrhea. These extragenital infections are frequently asymptomatic — the patient feels fine while harboring infection that can be transmitted to partners.

Site-matched testing means collecting samples from every site that was exposed: urine or urethral swab for urethral infection, rectal swab for anal exposure, and throat swab for oral exposure. Each site gets its own NAAT result, giving a complete picture of where infection exists.

This matters for treatment too — if rectal or pharyngeal infection is present, the treatment regimen and follow-up differ from simple urethritis. Missing an extragenital site means incomplete treatment and ongoing transmission risk.

• Rectal gonorrhea: often asymptomatic, needs rectal swab
• Pharyngeal gonorrhea: often asymptomatic, needs throat swab
• Each site gets its own NAAT result
• Extragenital infection affects treatment approach
• Complete coverage prevents missed infection and transmission
• Clinician asks about all sexual practices to determine sites

Treatment: Ceftriaxone and Partner Management

Urethral gonorrhea is treated with ceftriaxone — a single intramuscular injection of 500 mg (1 g if weight is 150 kg or more) — which is the current recommended first-line therapy globally. Gonorrhea has developed resistance to penicillin, tetracyclines and fluoroquinolones over decades, making ceftriaxone essential.

If chlamydia co-infection is possible or confirmed — which is common — doxycycline is added for 7 days. Patients should abstain from sexual activity for 7 days after treatment and until partners are treated, to prevent reinfection.

Partner notification is critical: partners from the exposure window need testing and treatment even without symptoms. Untreated partners are the most common cause of reinfection. Test-of-cure is recommended for pharyngeal infection and persistent symptoms — NAAT is repeated 7 to 14 days after treatment in those cases.

• Ceftriaxone 500 mg IM single injection — first-line treatment
• Doxycycline added if chlamydia co-infection present or suspected
• Abstain from sex for 7 days post-treatment and until partners treated
• Partner notification and treatment prevent reinfection
• Test-of-cure for pharyngeal infection or persistent symptoms
• Gonorrhea resistance makes correct antibiotic choice essential

Cost, Confidentiality and Booking

Urethral gonorrhea NAAT at Thamel Clinic typically costs Rs. 800 to Rs. 1,500 per site — urine or swab — with multi-site panels priced accordingly. The consultation fee of approximately Rs. 450 covers the clinical assessment, exposure history and testing plan.

Treatment with ceftriaxone is inexpensive — the injection typically costs Rs. 300 to Rs. 800 including administration. Added doxycycline for chlamydia coverage adds a small cost. Total cost for diagnosis and treatment is usually under Rs. 3,000.

Confidentiality is absolute — results are delivered privately, records are secure, and nothing is shared without consent. Same-day appointments are available for symptomatic patients who need prompt evaluation and treatment.

• Gonorrhea NAAT: Rs. 800–1,500 per site
• Multi-site panels priced per additional site
• Consultation approximately Rs. 450
• Ceftriaxone treatment: Rs. 300–800
• Results typically within 24 to 48 hours
• Same-day appointments for symptomatic patients

Urethral Gonorrhea Testing and Treatment Services

Prices are indicative in NPR; confirm current rates when booking. Multi-site testing adds cost per additional site.

Related Services & Guides